Also see: Charles Schwab, Polaris: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- STOCK COMMENTS / EPS CHANGES

Apple ( AAPL) price target boosted at Citi to $435 from $415. Another iPhone-driven blow out quarter, Citigroup said. Maintain Buy rating.

Apple ( AAPL) estimates, target upped at UBS. AAPL estimates were boosted through 2012, UBS said. iPhone sales continue to drive growth. Buy rating and new $495 price target.

Abbott Laboratories ( ABT) estimates upped at Morgan Stanley through 2012. Company is seeing better Humira sales. Overweight rating and $55 price target.

Albemarle ( ALB) price target raised at Citi to $75 from $70. Impressive 1Q11 beat, firing on all cylinders, Citigroup said. Maintain Buy rating.

Altria ( MO) estimates increased at UBS through 2012, UBS said. Company is seeing better pricing power. Buy rating and $28 price target.

American Express ( AXP) estimates boosted at Morgan Stanley through 2012, Morgan Stanley said. Company is releasing reserves and cutting costs. Overweight rating and $53 price target.

Cree ( CREE) estimates, target cut at UBS. Shares of CREE now seen reaching $41, according to UBS. Estimates also reduced, as the company has limited visibility. Neutral rating.

Quest Diagnostics ( DGX) price target higher at Citi. DGX shares now seen reaching $61, up from $58. Valuation too cheap for solid 1Q11 results, Citigroup said. Maintain Hold rating.

EMC ( EMC) price target raised at Citi to $32 from $28. Strong storage revenue, best is yet to come, Citigroup said. Maintain Buy rating.

EMC ( EMC) estimates, target raised at UBS. Shares of EMC now seen reaching $32, according to UBS. Estimates also increased, as new products are driving growth. Buy rating.

Eaton ( ETN) estimates, target boosted at UBS. Shares of ETN now seen reaching $57, according to UBS. Estimates also upped, given better end-market demand. Neutral rating.

Edwards LifeSciences ( EW) estimates upped at Morgan Stanley through 2012. Company is seeing favorable currency changes. Equal-weight rating.

F5 Networks ( FFIV) price target raised at Credit Suisse to $146 from $134. Strong 2Q11, plenty of room for upside, Credit Suisse said. Maintain Outperform rating.

Hanesbrands ( HBI) price target higher at Citi to $39 from $33. Significant 1Q11 beat, expect continued upside, Citigroup said. Maintain Buy rating.

Knight Transportation ( KNX) price target lower at Citi to $21 from $23 on disappointing 1Q11, Citigroup said. Maintain Buy rating.

Knight Transportation ( KNX) estimates reduced at Morgan Stanley through 2013. Company is seeing lower utilization rates and paying higher fuel costs. Equal-weight rating.

Lam Research ( LRCX) estimates lowered at UBS through 2012. Company is spending more on R&D. Buy rating and $59 price target.

Newfield Exploration ( NFX) numbers lowered at UBS. Shares of NFX now seen reaching $81. Estimates also cut, given the company's higher unit costs. Buy rating.

Qualcomm ( QCOM) price target raised at Citi to $67 from $60 as smartphones drive strong sales, Citigroup said. Maintain buy rating.

Qualcomm ( QCOM) estimates, target increased at UBS. QCOM estimates were raised through 2012, UBS said. Company remains leveraged to rising smartphone demand. Buy rating and new $70 price target.

Ralcorp ( RAH) estimates, target raised at UBS. Shares of RAH now seen reaching $70, according to UBS. Estimates also increased, as the company is seeing higher private-label sales. Neutral rating.

United Technologies ( UTX) price target boosted at Citi to $91 from $89. Carrier drives 1Q11 beat, further 2011 guidance increases, Citigroup said. Maintain Hold rating.

End of report.

This article was written by a staff member of TheStreet.

More from Stocks

Oracle Taking a 'Holistic' Approach to the Cloud

Oracle Taking a 'Holistic' Approach to the Cloud

IBM Stock Jumps After 'Cleanest Quarter in Years'

IBM Stock Jumps After 'Cleanest Quarter in Years'

Market Movers: January FOMC Meeting

Market Movers: January FOMC Meeting

Ford Reports Mixed Q4 Financial Results as International Performance Falters

Ford Reports Mixed Q4 Financial Results as International Performance Falters

TD Ameritrade CEO Breaks Down Earnings and 2019 Outlook

TD Ameritrade CEO Breaks Down Earnings and 2019 Outlook